MARKET DEFINITION

Numerous microalgal species have been used as sources of nutrient-dense foods, feed, and compounds that enhance health. Astaxanthin, a naturally occurring substance that is regarded as a super antioxidant, is most abundantly found in Haematococcus Pluvialis, one of the commercially significant microalgae. Compared to astaxanthin made from synthetic materials, astaxanthin produced naturally by H. Pluvialis has a significantly higher antioxidant capacity. However, the nutraceuticals, cosmetics, food, and aquaculture industries all use astaxanthin extensively. Astaxanthin is now understood to significantly reduce free radicals and oxidative stress, aiding the body in preserving health. Astaxanthin is a high-value microalgal product of the future that is in high demand due to its exceptional potency.

MARKET DYNAMICS

The rising demand for natural astaxanthin for nutraceuticals, rising demand for natural food colorants, and raising awareness of clean-label products are some of the main factors fueling the market's expansion. Additionally, changing consumer preferences for skin care will fuel market expansion. Astaxanthin has been demonstrated to increase skin moisture, moisture retention, elasticity, and smoothness while reducing fine lines and wrinkles. The high cost of production, however, is anticipated to impede market expansion. Furthermore, it is anticipated that the expanding use of natural astaxanthin in aquaculture and poultry will lead to prosperous opportunities.

REPORT SCOPE

The report titled “Global Haematococcus Market – Size, Share, Growth, Opportunities, and Competitive Analysis, 2022 – 2028” offers strategic visions into the global Haematococcus market along with the market size (Value in “US$ Mn”) for the historical period 2017 to 2021 and estimates for the forecast period 2022 to 2028. The RI report is an in-depth study of the global Haematococcus market with a strong focus on key market trends, vital player strategies, and market forecasts. The study also covers key market dynamics, including drivers, restraints, opportunities, challenges, and existing and upcoming pathways that help CXOs make critical business decisions effectively. The global Haematococcus Market is predicted to grow at a significant CAGR over the forecast period from 2022 to 2028.

GEOGRAPHICAL OVERVIEW

The research report includes a detailed overview of the industry comprising quantitative and qualitative information. It gives a broad overview of the worldwide market forecasts for major segments. It also includes market size and forecast projections for five key regions: North America, Europe, Asia-Pacific (APAC), South America, and the Middle East & Africa (MEA), for the years 2017 to 2028. The market is further divided by categories and countries within each province. The research scrutinizes and forecasts over 20 nations worldwide, as well as the present trend and possibilities in these regions.

MARKET SEGMENTATION

The Global Haematococcus Market is segmented based on Form, Sales Channel, End Use Industry, and region. Based on Form, the market has been segmented into Liquid Gel, Capsule and Pill, and Powder, whereas based on Sales Channel, the market comprises Online Stores, and Offline Stores. Based on End Use Industry, the market has been segmented into Pharmaceutical, Nutraceutical, Personal Care and Cosmetics, and Food & Beverage.

COMPETITION LANDSCAPE

The RI research report discusses noteworthy developments in the industry as well as organic and inorganic growth strategies being adopted by the Haematococcus market players. The report covers industry activities, including new product launches, mergers & acquisitions, business partnerships, and various expansion initiatives being undertaken by the active players in the market. These developments pave the path for various market participants to strengthen their positioning as well as expand their consumer base. The positive market outlook for the global Haematococcus market is anticipated to present lucrative growth opportunities to the market players. The report also offers detailed profiles of major players in the global Haematococcus market, emphasizing the strategic initiatives, financial information, SWOT analysis, and key development in the Haematococcus industry in the past three years.

Key players in the Global Haematococcus Market have adopted various organic as well as inorganic growth strategies to strengthen their market positioning. Prominent players in the market include:

• Cyanotech Corporation
• I.D.
• Parry India Limited
• BlueBio Tech GmbH
• Algatechnologies Ltd.
• Tianjin Norland Biotech Co., Ltd.
• AlgaeCan Biotech Ltd.
• AstaReal AB
• Yunnan Alphy Biotech Co., Ltd.
• Algae Health Sciences
• Fenchem
• Piveg, Inc.
• Algamo s.r.o.
• Atacama Bio Natural Products S.A.
• FjordAlg AS
• Sea & Sun Organic GmbH

COVID-19 IMPACT ANALYSIS ON GLOBAL HAEMATOCOCCUS MARKET

The COVID-19 pandemic is still a very personal, individual experience that is also a once-in-a-lifetime worldwide phenomenon with far-reaching consequences. The epidemic has wreaked havoc on people's lives in all nations and communities and also had a negative impact on global economic development in 2020, unlike anything seen in almost a century. The pandemic severely impacted key economies such as India, Brazil, the U.S., France, Russia, the UK, Italy, Turkey, and Argentina. According to estimates, the virus slowed global economic growth by -3.4 percent to -7.6 percent in 2020, with a rebound of 4.2 percent to 5.6 percent expected in 2021. In 2020, global commerce was expected to decline by 5.3 percent, but it is expected to rise by 8.0 percent in 2021.

In contrast to the global economic downturn in the first half of 2020, the economy began to showcase symptoms of a two-track recovery post the second quarter of 2020, with a fledgling rebound in developed nations, however, slower growth in emerging economies. The outbreak of the Covid-19 pandemic has not only resulted in halted production activity but has also disrupted the global supply chain. The research goes on to evaluate the current and future implications of the COVID-19 pandemic both on the target as well as broader market, thereby, providing accurate and trustworthy forecasts.

RESEARCH PROGRAM DESIGN

KEY QUESTIONS ANSWERED

1. What is the current size of the global Haematococcus market?
2. What will be the growth rate of the market over the forecast period?
3. Who are the key manufacturers/vendors in the Haematococcus market space?
4. What are the major market opportunities and market risks faced by the market?
5. What is the impact of COVID-19 on the market?
6. What are the revenue, sales, and price analysis of the top manufacturers in this market?
7. What are the key outcomes of Porter's five forces model?
8. Who are the distributors, traders, and vendors in the industry?

REASONS FOR BUYING THIS REPORT:

• The report offers comprehensive data on the Haematococcus market elaborating on the current state and future growth prospects both globally and regionally
• It offers a six-year market forecast trend evaluating the impact of drivers and restraints and supporting factors for growth
• The report offers deep-dive insights into each market segment and critical factors responsible for its growth
• The report presents precise picture of the dynamic competitive landscape which helps our client advance their market position
• The comprehensive analysis of the market along with the inclusion of analyst recommendations ensures that our clients make informed business decisions
• Cross-segment country-level analysis included in the report which provides granular analysis of more than 20+ countries covered in the report scope
• The study includes detailed profiles of major manufacturers to help our readers gain holistic overview of the market competitors and consequently align their business strategies

 
Chapter 1. Executive Summary
1.1. Market Outlook
1.2. Market Segment Outlook
1.3. Geography Outlook
1.4. Absolute $ Opportunity
 
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Scope, Definition, and Assumptions
2.3. Data Sources
2.3.1. Secondary Sources
2.3.1.1. Preliminary Data Mining
2.3.2. Primary Sources
2.3.2.1. Statistical End Use Industry
2.3.2.2. Data Triangulation
2.3.2.3. Research Objective
 
Chapter 3. Market Outlook
3.1. Introduction
3.2. Key Trends
3.2.1. Form Trends
3.2.2. Sales Channel Trends
3.2.3. End Use Industry Trends
3.3. Market Dynamics
3.3.1. Market Drivers
3.3.1.1. Impact Analysis of Market Drivers
3.3.2. Market Restraints
3.3.2.1. Impact Analysis of Market Restraints
3.3.3. Market Opportunities
3.3.3.1. Impact Analysis of Market Opportunities
3.3.4. Market Challenges
3.3.4.1. Impact Analysis of Market Challenges
3.4. Porter’s Five Forces’ Analysis
3.4.1. Bargaining Power of Suppliers
3.4.2. Bargaining Power of Buyers
3.4.3. Threat of New Entrant
3.4.4. Threat of Substitutes
3.4.5. Competitive Rivalry
3.5. Value Chain Analysis: Global Haematococcus Market
3.6. COVID-19 Impact Assessment in Haematococcus Market
3.6.1. Impact Assessment on Global Haematococcus Market
3.6.2. Market Trends and Opportunities in the Covid-19 Landscape
 
Chapter 4. Global Haematococcus Market Overview, By Form, 2017 - 2028 (USD Million)
4.1. Global Haematococcus Market Share, By Form, 2017 - 2028 (USD Million)
4.1.1. Liquid Gel
4.1.2. Capsule and Pill
4.1.3. Powder
 
Chapter 5. Global Haematococcus Market Overview, By Sales Channel, 2017 - 2028 (USD Million)
5.1. Global Haematococcus Market Share, By Sales Channel, 2017 - 2028 (USD Million)
5.1.1. Online Stores
5.1.2. Offline Stores
 
Chapter 6. Global Haematococcus Market Overview, By End Use Industry, 2017 - 2028 (USD Million)
6.1. Global Haematococcus Market Share, By End Use Industry, 2017 - 2028 (USD Million)
6.1.1. Pharmaceutical
6.1.2. Nutraceutical
6.1.3. Personal Care and Cosmetics
6.1.4. Food & Beverage
 
Chapter 7. Global Haematococcus Market Overview, By Geography, 2017 - 2028 (USD Million)
7.1. Global Haematococcus Market Share, By Geography, 2017 - 2028 (USD Million)
7.1.1. Market Sales Channel and Projections, by Countries, 2017 - 2028 (USD Million)
7.1.2. Market Share and CAGR Comparison, by Countries, 2021 (%)
 
Chapter 8. North America Haematococcus Market Overview, By Countries, 2017 - 2028 (USD Million)
8.1. North America Haematococcus Market Overview, 2017 - 2028 (USD Million)
8.1.1. Market Sales Channel and projections, 2017 - 2028 (USD Million)
8.1.2. North America Haematococcus Market Overview, By Form, 2017 - 2028 (USD Million)
8.1.3. North America Haematococcus Market Overview, By Sales Channel, 2017 - 2028 (USD Million)
8.1.4. North America Haematococcus Market Overview, By End Use Industry, 2017 - 2028 (USD Million)
8.1.5. North America Haematococcus Market Overview, By Vertical, 2017 - 2028 (USD Million)
8.1.6. North America Haematococcus Market Overview, By Application, 2017 - 2028 (USD Million)
8.2. North America Haematococcus Market Overview, By Countries, 2017 - 2028 (USD Million)
8.2.1. U.S. Haematococcus Market Overview, 2017 - 2028 (USD Million)
8.2.1.1. U.S. Haematococcus Market Overview, By Form, 2017 - 2028 (USD Million)
8.2.1.2. U.S. Haematococcus Market Overview, By Sales Channel, 2017 - 2028 (USD Million)
8.2.1.3. U.S. Haematococcus Market Overview, By End Use Industry, 2017 - 2028 (USD Million)
8.2.2. Canada Haematococcus Market Overview, 2017 - 2028 (USD Million)
8.2.2.1. Canada Haematococcus Market Overview, By Form, 2017 - 2028 (USD Million)
8.2.2.2. Canada Haematococcus Market Overview, By Sales Channel, 2017 - 2028 (USD Million)
8.2.2.3. Canada Haematococcus Market Overview, By End Use Industry, 2017 - 2028 (USD Million)
8.2.3. Mexico Haematococcus Market Overview, 2017 - 2028 (USD Million)
8.2.3.1. Mexico Haematococcus Market Overview, By Form, 2017 - 2028 (USD Million)
8.2.3.2. Mexico Haematococcus Market Overview, By Sales Channel, 2017 - 2028 (USD Million)
8.2.3.3. Mexico Haematococcus Market Overview, By End Use Industry, 2017 - 2028 (USD Million)
 
Chapter 9. Europe Haematococcus Market Overview, By Countries, 2017 - 2028 (USD Million)
9.1. Europe Haematococcus Market Overview, 2017 - 2028 (USD Million)
9.1.1. Market Sales Channel and projections, 2017 - 2028 (USD Million)
9.1.2. Europe Haematococcus Market Overview, By Form, 2017 - 2028 (USD Million)
9.1.3. Europe Haematococcus Market Overview, By Sales Channel, 2017 - 2028 (USD Million)
9.1.4. Europe Haematococcus Market Overview, By End Use Industry, 2017 - 2028 (USD Million)
9.2. Europe Haematococcus Market Overview, By Countries, 2017 - 2028 (USD Million)
9.2.1. Germany Haematococcus Market Overview, 2017 - 2028 (USD Million)
9.2.1.1. Germany Haematococcus Market Overview, By Form, 2017 - 2028 (USD Million)
9.2.1.2. Germany Haematococcus Market Overview, By Sales Channel, 2017 - 2028 (USD Million)
9.2.1.3. Germany Haematococcus Market Overview, By End Use Industry, 2017 - 2028 (USD Million)
9.2.2. France Haematococcus Market Overview, 2017 - 2028 (USD Million)
9.2.2.1. France Haematococcus Market Overview, By Form, 2017 - 2028 (USD Million)
9.2.2.2. France Haematococcus Market Overview, By Sales Channel, 2017 - 2028 (USD Million)
9.2.2.3. France Haematococcus Market Overview, By End Use Industry, 2017 - 2028 (USD Million)
9.2.3. UK Haematococcus Market Overview, 2017 - 2028 (USD Million)
9.2.3.1. UK Haematococcus Market Overview, By Form, 2017 - 2028 (USD Million)
9.2.3.2. UK Haematococcus Market Overview, By Sales Channel, 2017 - 2028 (USD Million)
9.2.3.3. UK Haematococcus Market Overview, By End Use Industry, 2017 - 2028 (USD Million)
9.2.4. Italy Haematococcus Market Overview, 2017 - 2028 (USD Million)
9.2.4.1. Italy Haematococcus Market Overview, By Form, 2017 - 2028 (USD Million)
9.2.4.2. Italy Haematococcus Market Overview, By Sales Channel, 2017 - 2028 (USD Million)
9.2.4.3. Italy Haematococcus Market Overview, By End Use Industry, 2017 - 2028 (USD Million)
9.2.5. Spain Haematococcus Market Overview, 2017 - 2028 (USD Million)
9.2.5.1. Spain Haematococcus Market Overview, By Form, 2017 - 2028 (USD Million)
9.2.5.2. Spain Haematococcus Market Overview, By Sales Channel, 2017 - 2028 (USD Million)
9.2.5.3. Spain Haematococcus Market Overview, By End Use Industry, 2017 - 2028 (USD Million)
9.2.6. NORDIC Haematococcus Market Overview, 2017 - 2028 (USD Million)
9.2.6.1. NORDIC Haematococcus Market Overview, By Form, 2017 - 2028 (USD Million)
9.2.6.2. NORDIC Haematococcus Market Overview, By Sales Channel, 2017 - 2028 (USD Million)
9.2.6.3. NORDIC Haematococcus Market Overview, By End Use Industry, 2017 - 2028 (USD Million)
9.2.7. Russia and CIS Haematococcus Market Overview, 2017 - 2028 (USD Million)
9.2.7.1. Russia and CIS Haematococcus Market Overview, By Form, 2017 - 2028 (USD Million)
9.2.7.2. Russia and CIS Haematococcus Market Overview, By Sales Channel, 2017 - 2028 (USD Million)
9.2.7.3. Russia and CIS Haematococcus Market Overview, By End Use Industry, 2017 - 2028 (USD Million)
9.2.8. Rest of Europe Haematococcus Market Overview, 2017 - 2028 (USD Million)
9.2.8.1. Rest of Europe Haematococcus Market Overview, By Form, 2017 - 2028 (USD Million)
9.2.8.2. Rest of Europe Haematococcus Market Overview, By Sales Channel, 2017 - 2028 (USD Million)
9.2.8.3. Rest of Europe Haematococcus Market Overview, By End Use Industry, 2017 - 2028 (USD Million)
 
Chapter 10. Asia Pacific Haematococcus Market Overview, By Countries, 2017 - 2028 (USD Million)
10.1. Asia Pacific Haematococcus Market Overview, 2017 - 2028 (USD Million)
10.1.1. Market Sales Channel and projections, 2017 - 2028 (USD Million)
10.1.2. Asia Pacific Haematococcus Market Overview, By Form, 2017 - 2028 (USD Million)
10.1.3. Asia Pacific Haematococcus Market Overview, By Sales Channel, 2017 - 2028 (USD Million)
10.1.4. Asia Pacific Haematococcus Market Overview, By End Use Industry, 2017 - 2028 (USD Million)
10.2. Asia Pacific Haematococcus Market Overview, By Countries, 2017 - 2028 (USD Million)
10.2.1. India Haematococcus Market Overview, 2017 - 2028 (USD Million)
10.2.1.1. India Haematococcus Market Overview, By Form, 2017 - 2028 (USD Million)
10.2.1.2. India Haematococcus Market Overview, By Sales Channel, 2017 - 2028 (USD Million)
10.2.1.3. India Haematococcus Market Overview, By End Use Industry, 2017 - 2028 (USD Million)
10.2.2. China Haematococcus Market Overview, 2017 - 2028 (USD Million)
10.2.2.1. China Haematococcus Market Overview, By Form, 2017 - 2028 (USD Million)
10.2.2.2. China Haematococcus Market Overview, By Sales Channel, 2017 - 2028 (USD Million)
10.2.2.3. China Haematococcus Market Overview, By End Use Industry, 2017 - 2028 (USD Million)
10.2.3. Japan Haematococcus Market Overview, 2017 - 2028 (USD Million)
10.2.3.1. Japan Haematococcus Market Overview, By Form, 2017 - 2028 (USD Million)
10.2.3.2. Japan Haematococcus Market Overview, By Sales Channel, 2017 - 2028 (USD Million)
10.2.3.3. Japan Haematococcus Market Overview, By End Use Industry, 2017 - 2028 (USD Million)
10.2.4. ASEAN Haematococcus Market Overview, 2017 - 2028 (USD Million)
10.2.4.1. ASEAN Haematococcus Market Overview, By Form, 2017 - 2028 (USD Million)
10.2.4.2. ASEAN Haematococcus Market Overview, By Sales Channel, 2017 - 2028 (USD Million)
10.2.4.3. ASEAN Haematococcus Market Overview, By End Use Industry, 2017 - 2028 (USD Million)
10.2.5. South Korea Haematococcus Market Overview, 2017 - 2028 (USD Million)
10.2.5.1. South Korea Haematococcus Market Overview, By Form, 2017 - 2028 (USD Million)
10.2.5.2. South Korea Haematococcus Market Overview, By Sales Channel, 2017 - 2028 (USD Million)
10.2.5.3. South Korea Haematococcus Market Overview, By End Use Industry, 2017 - 2028 (USD Million)
10.2.6. Australia Haematococcus Market Overview, 2017 - 2028 (USD Million)
10.2.6.1. Australia Haematococcus Market Overview, By Form, 2017 - 2028 (USD Million)
10.2.6.2. Australia Haematococcus Market Overview, By Sales Channel, 2017 - 2028 (USD Million)
10.2.6.3. Australia Haematococcus Market Overview, By End Use Industry, 2017 - 2028 (USD Million)
10.2.7. Rest of Asia Pacific Haematococcus Market Overview, 2017 - 2028 (USD Million)
10.2.7.1. Rest of Asia Pacific Haematococcus Market Overview, By Form, 2017 - 2028 (USD Million)
10.2.7.2. Rest of Asia Pacific Haematococcus Market Overview, By Sales Channel, 2017 - 2028 (USD Million)
10.2.7.3. Rest of Asia Pacific Haematococcus Market Overview, By End Use Industry, 2017 - 2028 (USD Million)
 
Chapter 11. South America Haematococcus Market Overview, By Countries, 2017 - 2028 (USD Million)
11.1. South America Haematococcus Market Overview, 2017 - 2028 (USD Million)
11.1.1. Market Sales Channel and projections, 2017 - 2028 (USD Million)
11.1.2. South America Haematococcus Market Overview, By Form, 2017 - 2028 (USD Million)
11.1.3. South America Haematococcus Market Overview, By Sales Channel, 2017 - 2028 (USD Million)
11.1.4. South America Haematococcus Market Overview, By End Use Industry, 2017 - 2028 (USD Million)
11.2. South America Haematococcus Market Overview, By Countries, 2017 - 2028 (USD Million)
11.2.1. Brazil Haematococcus Market Overview, 2017 - 2028 (USD Million)
11.2.1.1. Brazil Haematococcus Market Overview, By Form, 2017 - 2028 (USD Million)
11.2.1.2. Brazil Haematococcus Market Overview, By Sales Channel, 2017 - 2028 (USD Million)
11.2.1.3. Brazil Haematococcus Market Overview, By End Use Industry, 2017 - 2028 (USD Million)
11.2.2. Argentina Haematococcus Market Overview, 2017 - 2028 (USD Million)
11.2.2.1. Argentina Haematococcus Market Overview, By Form, 2017 - 2028 (USD Million)
11.2.2.2. Argentina Haematococcus Market Overview, By Sales Channel, 2017 - 2028 (USD Million)
11.2.2.3. Argentina Haematococcus Market Overview, By End Use Industry, 2017 - 2028 (USD Million)
11.2.3. Rest of South America Haematococcus Market Overview, 2017 - 2028 (USD Million)
11.2.3.1. Rest of South America Haematococcus Market Overview, By Form, 2017 - 2028 (USD Million)
11.2.3.2. Rest of South America Haematococcus Market Overview, By Sales Channel, 2017 - 2028 (USD Million)
11.2.3.3. Rest of South America Haematococcus Market Overview, By End Use Industry, 2017 - 2028 (USD Million)
 
Chapter 12. Middle East & Africa Haematococcus Market Overview, By Countries, 2017 - 2028 (USD Million)
12.1. Middle East & Africa Haematococcus Market Overview, 2017 - 2028 (USD Million)
12.1.1. Market Sales Channel and projections, 2017 - 2028 (USD Million)
12.1.2. Middle East & Africa Haematococcus Market Overview, By Form, 2017 - 2028 (USD Million)
12.1.3. Middle East & Africa Haematococcus Market Overview, By Sales Channel, 2017 - 2028 (USD Million)
12.1.4. Middle East & Africa Haematococcus Market Overview, By End Use Industry, 2017 - 2028 (USD Million)
12.2. Middle East & Africa Haematococcus Market Overview, By Countries, 2017 - 2028 (USD Million)
12.2.1. GCC Haematococcus Market Overview, 2017 - 2028 (USD Million)
12.2.1.1. GCC Haematococcus Market Overview, By Form, 2017 - 2028 (USD Million)
12.2.1.2. GCC Haematococcus Market Overview, By Sales Channel, 2017 - 2028 (USD Million)
12.2.1.3. GCC Haematococcus Market Overview, By End Use Industry, 2017 - 2028 (USD Million)
12.2.2. South Africa Haematococcus Market Overview, 2017 - 2028 (USD Million)
12.2.2.1. South Africa Haematococcus Market Overview, By Form, 2017 - 2028 (USD Million)
12.2.2.2. South Africa Haematococcus Market Overview, By Sales Channel, 2017 - 2028 (USD Million)
12.2.2.3. South Africa Haematococcus Market Overview, By End Use Industry, 2017 - 2028 (USD Million)
12.2.3. Rest of Middle East & Africa Haematococcus Market Overview, 2017 - 2028 (USD Million)
12.2.3.1. Rest of Middle East & Africa Haematococcus Market Overview, By Form, 2017 - 2028 (USD Million)
12.2.3.2. Rest of Middle East & Africa Haematococcus Market Overview, By Sales Channel, 2017 - 2028 (USD Million)
12.2.3.3. Rest of Middle East & Africa Haematococcus Market Overview, By End Use Industry, 2017 - 2028 (USD Million)
 
Chapter 13. Competitive Landscape
13.1. Competitive Environment, 2021
13.2. Strategic Framework
13.2.1. Partnership/Collaborations/Agreement
13.2.2. Expansion
13.2.3. Mergers & Acquisitions
13.2.4. New Product Development
 
 
Chapter 14. Key Vendor Analysis
14.1. Cyanotech Corporation
14.1.1. Business Overview
14.1.2. Product Benchmarking
14.1.3. Financial Data
14.1.4. Strategic Overview
14.1.5. Key Developments
14.1.6. SWOT Analysis
14.2. E.I.D.
14.2.1. Business Overview
14.2.2. Product Benchmarking
14.2.3. Financial Data
14.2.4. Strategic Overview
14.2.5. Key Developments
14.2.6. SWOT Analysis
14.3. Parry India Limited
14.3.1. Business Overview
14.3.2. Product Benchmarking
14.3.3. Financial Data
14.3.4. Strategic Overview
14.3.5. Key Developments
14.3.6. SWOT Analysis
14.4. BlueBio Tech GmbH
14.4.1. Business Overview
14.4.2. Product Benchmarking
14.4.3. Financial Data
14.4.4. Strategic Overview
14.4.5. Key Developments
14.4.6. SWOT Analysis
14.5. Algatechnologies Ltd.
14.5.1. Business Overview
14.5.2. Product Benchmarking
14.5.3. Financial Data
14.5.4. Strategic Overview
14.5.5. Key Developments
14.5.6. SWOT Analysis
14.6. Tianjin Norland Biotech Co., Ltd.
14.6.1. Business Overview
14.6.2. Product Benchmarking
14.6.3. Financial Data
14.6.4. Strategic Overview
14.6.5. Key Developments
14.6.6. SWOT Analysis
14.7. AlgaeCan Biotech Ltd.
14.7.1. Business Overview
14.7.2. Product Benchmarking
14.7.3. Financial Data
14.7.4. Strategic Overview
14.7.5. Key Developments
14.7.6. SWOT Analysis
14.8. AstaReal AB
14.8.1. Business Overview
14.8.2. Product Benchmarking
14.8.3. Financial Data
14.8.4. Strategic Overview
14.8.5. Key Developments
14.8.6. SWOT Analysis
14.9. Yunnan Alphy Biotech Co., Ltd.
14.9.1. Business Overview
14.9.2. Product Benchmarking
14.9.3. Financial Data
14.9.4. Strategic Overview
14.9.5. Key Developments
14.9.6. SWOT Analysis
14.10. Algae Health Sciences
1.1.1. Business Overview
1.1.2. Product Benchmarking
1.1.3. Financial Data
1.1.4. Strategic Overview
1.1.5. Key Developments
1.1.6. SWOT Analysis
14.11. Fenchem
1.1.7. Business Overview
1.1.8. Product Benchmarking
1.1.9. Financial Data
1.1.10. Strategic Overview
1.1.11. Key Developments
1.1.12. SWOT Analysis
14.12. Piveg, Inc.
1.1.13. Business Overview
1.1.14. Product Benchmarking
1.1.15. Financial Data
1.1.16. Strategic Overview
1.1.17. Key Developments
1.1.18. SWOT Analysis
14.13. Algamo s.r.o.
1.1.19. Business Overview
1.1.20. Product Benchmarking
1.1.21. Financial Data
1.1.22. Strategic Overview
1.1.23. Key Developments
1.1.24. SWOT Analysis
14.14. Atacama Bio Natural Products S.A.
1.1.25. Business Overview
1.1.26. Product Benchmarking
1.1.27. Financial Data
1.1.28. Strategic Overview
1.1.29. Key Developments
1.1.30. SWOT Analysis
14.15. FjordAlg AS
1.1.31. Business Overview
1.1.32. Product Benchmarking
1.1.33. Financial Data
1.1.34. Strategic Overview
1.1.35. Key Developments
1.1.36. SWOT Analysis
14.16. Sea & Sun Organic GmbH
1.1.37. Business Overview
1.1.38. Product Benchmarking
1.1.39. Financial Data
1.1.40. Strategic Overview
1.1.41. Key Developments
1.1.42. SWOT Analysis
 
Chapter 12. Future Outlook of the Market